Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Various exogenous and endogenous toxins encompass a diverse array of chemical and biological entities that exert deleterious effects on physiological processes. Exogenous toxins include xenobiotics such as heavy metals, pesticides, and bacterial or fungal toxins, while endogenous toxins comprise metabolic byproducts like ammonia, urea, and reactive oxygen species that accumulate during disease states (StatPearls, 2023). Unlike traditional drug targets such as receptors or enzymes, these toxins are the pathogenic agents themselves, which therapeutic interventions aim to neutralize, sequester, or eliminate (NIH, 2022). Common pharmacological approaches include the use of activated charcoal for adsorption, chelating agents for metal removal, and monoclonal antibodies or Fab fragments for specific toxin neutralization (PubChem, 2024). The clinical relevance of managing these substances spans emergency toxicology, environmental medicine, and the treatment of metabolic disorders like hepatic encephalopathy or uremia (PubMed, 2021). Therapeutic challenges include the rapid distribution of toxins into tissues and the potential for non-specific binding of essential minerals by chelators. Overall, the neutralization of these substances is a cornerstone of detoxification and critical care medicine.
Neutralization, adsorption, chelation, or sequestration of harmful chemical or biological agents.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Various exogenous and endogenous toxins.